Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/7335
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPutri Kinanti, Diajeng-
dc.contributor.authorAthiyah, Umi-
dc.contributor.authorNita, Yunita-
dc.contributor.authorNoor Diansyah, Muhammad-
dc.date.accessioned2024-11-06T04:40:11Z-
dc.date.available2024-11-06T04:40:11Z-
dc.date.issued2021-11-30-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/7335-
dc.description.abstractAbstract Background: Diabetic gangrene is a complication of diabetes mellitus that imposes a substantial financial burden on patients and their families as well as the health care system. Objective: To determine the total cost of disease, and the difference between real cost and INA CBG rate for diabetic gangrene inpatients from January - December 2017 at Universitas Airlangga Hospital, Surabaya Methods: The study was conducted retrospectively by using a total sampling method. The perspective used was the hospital perspective. This study's direct medical costs were laboratory, drug and consumable medical device costs, medical equipment rental, radiology examination, red cross, oxygen, service, and room costs. Data analysis was performed using an independent samples t-test. Results: The results showed that 148 patients met the inclusion criteria. The total real cost of diabetic gangrene inpatients at Universitas Airlangga Hospital in 2017 was IDR 1,339,949,381, and the total INA CBG rate for inpatients with diabetic gangrene was IDR 1,365,047,500. The difference was (p = 0.000) between real cost and INA CBG rate. Conclusion: There is a difference between the actual cost and the INA CBG rate for diabetic gangrene inpatients. Keywords: national health insurance, cost analysis, direct cost, diabetic gangrene, diabetes mellitusen_US
dc.publisherFaculty of Pharmacy Univesrsitas Airlanggaen_US
dc.subjectnational health insurance,en_US
dc.subjectcost analysis,en_US
dc.subjectdirect cost,en_US
dc.subjectdiabetic gangrene,en_US
dc.subjectdiabetes mellitusen_US
dc.titleComparative Analysis of Actual Cost and INA CBG Rate in Diabetic Gangrene Inpatientsen_US
dc.typeArticleen_US
Appears in Collections:VOL 8 NO 3 2021

Files in This Item:
File Description SizeFormat 
283-292.pdf163.55 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.